Overview

Effect of Statin Therapy on C-Reactive Protein Levels in Patients With Chronic Obstructive Lung Disease (COPD)

Status:
Unknown status
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
Hypothesis for this pilot study is that simvastatin will lower the levels of CRP and ET-1 in COPD patients.
Phase:
Phase 1
Details
Lead Sponsor:
VA Loma Linda Health Care System
Treatments:
Simvastatin